SECsense Logo

Cyclo Therapeutics, Inc. 8-K Report: Key Insights & Stock Info

$CYTH
Form 8-K
Filed on: 2024-12-23
Source
Cyclo Therapeutics, Inc. 8-K Report: Key Insights & Stock Info

Based on the provided XML section from the financial report, here are the key insights and important information extracted:

  1. Entity Information:
  • Company Name: Cyclo Therapeutics, Inc.
  • CIK Number: 0000922247
  • State of Incorporation: Nevada (NV)
  • SEC File Number: 001-39780
  • EIN: 59-3029743
  • Address: 6714 NW 16th Street, Suite B, Gainesville, FL 32653
  • Phone Number: 386-418-8060
  1. Security Information:
  • Common Stock:
    • Par Value: $0.0001 per share
    • Ticker Symbol: CYTH (traded on NASDAQ)
  • Warrants:
    • Ticker Symbol: CYTHW (traded on NASDAQ)
  1. Report Context:
  • Report Type: Form 8-K
  • Filing Date: December 18, 2024
  • Report Period: The reporting period is the same as the filing date (December 18, 2024).
  1. Class of Stock:
  • The financial report references common stock and warrants to purchase common stock, indicating the potential for equity dilution or capital raising strategies.
  1. XBRL Context:
  • The report uses XBRL (eXtensible Business Reporting Language) for structured data, which is standard for SEC filings, allowing for easier analysis and data extraction.
  1. Regulatory Compliance:
  • The filing complies with SEC regulations, as indicated by the use of specific namespaces such as US GAAP for financial reporting standards.

Summary:

Cyclo Therapeutics, Inc. filed an 8-K report on December 18, 2024, detailing its common stock and associated warrants. The company is incorporated in Nevada and trades on NASDAQ under the ticker symbols CYTH and CYTHW. The report utilizes XBRL for compliance with SEC standards, indicating adherence to regulatory requirements.